What is GNOM's expense ratio?

Global X Genomics & Biotechnology ETF charges a net expense ratio of 0.500%.

How large is Global X Genomics & Biotechnology ETF?

GNOM holds $87 in assets under management.

What index does GNOM track?

Global X Genomics & Biotechnology ETF tracks Solactive Genomics NR USD as its primary benchmark.

When did GNOM launch?

Global X Genomics & Biotechnology ETF launched on April 5, 2019.

What currency does GNOM trade in?

GNOM trades in USD on Nasdaq - All Markets.

Global X Genomics & Biotechnology ETF

Compare

GNOM USExchange-Traded Fund

$54.38

Thematic and TechnologyGenomicsStrategic Beta · Multi-Factor

Compare

About this fund

Global X Genomics & Biotechnology ETF (GNOM) is a Thematic and Technology ETF managed by Global X Management Company LLC, listed on Nasdaq - All Markets in USD. It charges a 0.50% net expense ratio and holds $87 in assets as of Aug 13, 2026. The fund tracks Solactive Genomics NR USD and was launched on Apr 5, 2019.

Benchmark: Solactive Genomics NR USD
Advisor: Global X Management Company LLC
Exchange: Nasdaq - All Markets
Distribution: Semi-Annually

AUM: $87
Expense Ratio: 0.50%
Yield (12-mo): -0.24%
Morningstar Rating
Benchmark: Solactive Genomics NR USD
52-Week Range
Avg Daily Vol: 25.9K
Inception: Apr 5, 2019

NAV & premium/discount

as of Aug 12, 2026

NAV

$59.61

Premium / Discount

-0.13%

Median Prem/Disc (1Y)

-0.07%

52-Wk NAV High

$59.61

52-Wk NAV Low

$36.40

Premium/discount is how far the market price trades above (+) or below (−) the fund's net asset value (reported in USD).

Risk metrics

vs benchmark Solactive Genomics NR USD

3-year risk statistics are not currently available for this fund.

Risk statistics are 3-year, month-end-based.

Trailing returns

As of Aug 13, 2026

-0.26%

+5.69%

+5.08%

+27.37%

+31.23%

YTD

+31.09%

+69.56%

3Y ann.

+10.16%

5Y ann.

-8.30%

10Y ann.

—

Calendar-year returns

Morningstar daily closes

Trading & liquidity

as of Aug 12, 2026

Avg Vol (1W)

21.3K

Avg Vol (1M)

23.5K

Avg Vol (3M)

25.9K

Avg Vol (1Y)

14.1K

Avg Spread

0.484%

Average daily share volume over each trailing window. Spread is the average bid-ask spread as a percentage of price — lower means cheaper to trade.

Top 10 holdings

Source: Morningstar

Fees & expenses

Net expense

0.50%

Gross expense

0.50%

Management fee

0.50%

Distributions

Frequency: Semi-Annually

12-month yield

-0.24%

Recent payments per share (USD)

Jun 29, 2026

0.0579 USD

Dec 30, 2025

0.5912 USD

Jun 27, 2025

0.0331 USD

Dec 30, 2021

0.0260 USD

Classification

Frequently asked questions

What is GNOM's expense ratio?: Global X Genomics & Biotechnology ETF charges a net expense ratio of 0.500%.
How large is Global X Genomics & Biotechnology ETF?: GNOM holds $87 in assets under management.
What index does GNOM track?: Global X Genomics & Biotechnology ETF tracks Solactive Genomics NR USD as its primary benchmark.
When did GNOM launch?: Global X Genomics & Biotechnology ETF launched on April 5, 2019.
What currency does GNOM trade in?: GNOM trades in USD on Nasdaq - All Markets.